Literature DB >> 3421893

Inositol 1:2(cyclic),4,5-trisphosphate is not a major product of inositol phospholipid metabolism in vasopressin-stimulated WRK1 cells.

N S Wong1, C J Barker, S B Shears, C J Kirk, R H Michell.   

Abstract

1. A method has been devised for quenching cell incubations with an aqueous phenol/chloroform/EDTA mixture of neutral pH, to allow the analysis of acid-labile cell components. 2. Using this method, we have searched for the appearance of Ins(1:2cyclic,4,5)P3 [inositol 1:2(cyclic),4,5-trisphosphate] in WRK1 mammary tumour cells that were labelled to high specific radioactivity with [3H]inositol and then stimulated with 0.4 microM-vasopressin. 3. Vasopressin caused a very rapid accumulation of Ins(1,4,5)P3 (inositol 1,4,5-trisphosphate), followed by a slower decline towards the original concentration. An acid-labile and inositol-labelled compound with the chromatographic properties of Ins(1:2cyclic,4,5)P3 was present in unstimulated cells at less than 5% of the elevated concentration of Ins(1,4,5)P3. Its concentration rose 2-3-fold during stimulation for 3 min, at which time its concentration was about 5% of the elevated concentration of Ins(1,4,5)P3. 4. We conclude that Ins(1,4,5)P3 is the major product of phosphoinositidase C-catalysed phosphatidylinositol 4,5-bisphosphate hydrolysis in vasopressin-stimulated WRK1 cells. Ins(1:2cyclic,4,5)P3 is unlikely to be an important intracellular messenger in these cells, at least during the first few minutes of stimulation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3421893      PMCID: PMC1149098          DOI: 10.1042/bj2520001

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1.  Metabolism of D-myo-inositol 1,3,4,5-tetrakisphosphate by rat liver, including the synthesis of a novel isomer of myo-inositol tetrakisphosphate.

Authors:  S B Shears; J B Parry; E K Tang; R F Irvine; R H Michell; C J Kirk
Journal:  Biochem J       Date:  1987-08-15       Impact factor: 3.857

2.  The enzymic formation of myoinositol 1:2-cyclic phosphate from phosphatidylinositol.

Authors:  R M Dawson; N Freinkel; F B Jungalwala; N Clarke
Journal:  Biochem J       Date:  1971-05       Impact factor: 3.857

3.  The phosphorylation potential generated by respiring mitochondria.

Authors:  E C Slater; J Rosing; A Mol
Journal:  Biochim Biophys Acta       Date:  1973-04-05

Review 4.  Formation and actions of calcium-mobilizing messenger, inositol 1,4,5-trisphosphate.

Authors:  J W Putney
Journal:  Am J Physiol       Date:  1987-02

5.  Inositol 1,2-cyclic 4,5-trisphosphate is not a product of muscarinic receptor-stimulated phosphatidylinositol 4,5-bisphosphate hydrolysis in rat parotid glands.

Authors:  P T Hawkins; C P Berrie; A J Morris; C P Downes
Journal:  Biochem J       Date:  1987-04-01       Impact factor: 3.857

6.  Partial purification and characterization of membrane-bound and cytosolic phosphatidylinositol-specific phospholipases C from murine thymocytes.

Authors:  P Wang; S Toyoshima; T Osawa
Journal:  J Biochem       Date:  1986-10       Impact factor: 3.387

7.  Inositol 1,2-cyclic 4,5-trisphosphate concentration relative to inositol 1,4,5-trisphosphate in pancreatic minilobules on stimulation with carbamylcholine in the absence of lithium. Possible role as a second messenger in long- but not short-term responses.

Authors:  J F Dixon; L E Hokin
Journal:  J Biol Chem       Date:  1987-10-15       Impact factor: 5.157

8.  The formation of inositol 1,2-cyclic 4,5-trisphosphate and inositol 1,2-cyclic 4-bisphosphate on stimulation of mouse pancreatic minilobules with carbamylcholine.

Authors:  M C Sekar; J F Dixon; L E Hokin
Journal:  J Biol Chem       Date:  1987-01-05       Impact factor: 5.157

9.  Inositol(3,4)bisphosphate and inositol(1,3)bisphosphate in GH4 cells--evidence for complex breakdown of inositol(1,3,4)trisphosphate.

Authors:  R F Irvine; A J Letcher; D J Lander; J P Heslop; M J Berridge
Journal:  Biochem Biophys Res Commun       Date:  1987-02-27       Impact factor: 3.575

10.  Inositol 1,3,4,5-tetrakisphosphate and not phosphatidylinositol 3,4-bisphosphate is the probable precursor of inositol 1,3,4-trisphosphate in agonist-stimulated parotid gland.

Authors:  C P Downes; P T Hawkins; R F Irvine
Journal:  Biochem J       Date:  1986-09-01       Impact factor: 3.857

View more
  8 in total

1.  Relationships between the degree of cross-linking of surface immunoglobulin and the associated inositol 1,4,5-trisphosphate and Ca2+ signals in human B cells.

Authors:  F M McConnell; S B Shears; P J Lane; M S Scheibel; E A Clark
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

Review 2.  Metabolism of the inositol phosphates produced upon receptor activation.

Authors:  S B Shears
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

3.  Inositol 1:2-cyclic,4,5-trisphosphate is only a weak agonist at inositol 1,4,5-trisphosphate receptors.

Authors:  A L Willcocks; J Strupish; R F Irvine; S R Nahorski
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

4.  An analysis of myo-[3H]inositol trisphosphates found in myo-[3H]inositol prelabelled avian erythrocytes.

Authors:  L R Stephens; P T Hawkins; C P Downes
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

5.  The Ins(1,4,5)P3 binding site of bovine adrenocortical microsomes: function and regulation.

Authors:  S Palmer; M J Wakelam
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

6.  The interrelationships of the inositol phosphates formed in vasopressin-stimulated WRK-1 rat mammary tumour cells.

Authors:  C J Barker; N S Wong; S M Maccallum; P A Hunt; R H Michell; C J Kirk
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

7.  The inositol phosphates in WRK1 rat mammary tumour cells.

Authors:  N S Wong; C J Barker; A J Morris; A Craxton; C J Kirk; R H Michell
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

8.  Complex changes in cellular inositol phosphate complement accompany transit through the cell cycle.

Authors:  Christopher J Barker; Joanne Wright; Philip J Hughes; Christopher J Kirk; Robert H Michell
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.